Cooper Gross Margin 2010-2024 | COO
Current and historical gross margin for Cooper (COO) over the last 10 years. The current gross profit margin for Cooper as of January 31, 2024 is %.
| Cooper Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-01-31 |
$3.67B |
$2.42B |
66.09% |
| 2023-10-31 |
$3.59B |
$2.36B |
65.63% |
| 2023-07-31 |
$3.51B |
$2.29B |
65.14% |
| 2023-04-30 |
$3.43B |
$2.23B |
65.10% |
| 2023-01-31 |
$3.38B |
$2.18B |
64.53% |
| 2022-10-31 |
$3.31B |
$2.14B |
64.69% |
| 2022-07-31 |
$3.22B |
$2.11B |
65.39% |
| 2022-04-30 |
$3.14B |
$2.07B |
65.91% |
| 2022-01-31 |
$3.03B |
$2.02B |
66.79% |
| 2021-10-31 |
$2.92B |
$1.96B |
66.92% |
| 2021-07-31 |
$2.85B |
$1.88B |
65.99% |
| 2021-04-30 |
$2.66B |
$1.72B |
64.75% |
| 2021-01-31 |
$2.47B |
$1.56B |
63.26% |
| 2020-10-31 |
$2.43B |
$1.54B |
63.18% |
| 2020-07-31 |
$2.44B |
$1.57B |
64.20% |
| 2020-04-30 |
$2.54B |
$1.66B |
65.18% |
| 2020-01-31 |
$2.67B |
$1.77B |
66.12% |
| 2019-10-31 |
$2.65B |
$1.76B |
66.26% |
| 2019-07-31 |
$2.61B |
$1.73B |
66.32% |
| 2019-04-30 |
$2.59B |
$1.71B |
65.88% |
| 2019-01-31 |
$2.57B |
$1.68B |
65.38% |
| 2018-10-31 |
$2.53B |
$1.63B |
64.47% |
| 2018-07-31 |
$2.44B |
$1.56B |
63.69% |
| 2018-04-30 |
$2.34B |
$1.49B |
63.49% |
| 2018-01-31 |
$2.23B |
$1.42B |
63.86% |
| 2017-10-31 |
$2.14B |
$1.37B |
63.81% |
| 2017-07-31 |
$2.10B |
$1.31B |
62.40% |
| 2017-04-30 |
$2.06B |
$1.27B |
61.75% |
| 2017-01-31 |
$2.02B |
$1.22B |
60.68% |
| 2016-10-31 |
$1.97B |
$1.17B |
59.65% |
| 2016-07-31 |
$1.91B |
$1.13B |
59.37% |
| 2016-04-30 |
$1.85B |
$1.09B |
58.69% |
| 2016-01-31 |
$1.80B |
$1.06B |
58.57% |
| 2015-10-31 |
$1.80B |
$1.07B |
59.51% |
| 2015-07-31 |
$1.81B |
$1.10B |
60.61% |
| 2015-04-30 |
$1.78B |
$1.11B |
62.08% |
| 2015-01-31 |
$1.76B |
$1.11B |
62.89% |
| 2014-10-31 |
$1.72B |
$1.09B |
63.60% |
| 2014-07-31 |
$1.66B |
$1.08B |
64.78% |
| 2014-04-30 |
$1.64B |
$1.06B |
64.78% |
| 2014-01-31 |
$1.61B |
$1.05B |
65.03% |
| 2013-10-31 |
$1.59B |
$1.03B |
64.61% |
| 2013-07-31 |
$1.57B |
$1.02B |
64.57% |
| 2013-04-30 |
$1.54B |
$0.99B |
64.17% |
| 2013-01-31 |
$1.50B |
$0.95B |
63.64% |
| 2012-10-31 |
$1.45B |
$0.92B |
63.94% |
| 2012-07-31 |
$1.41B |
$0.90B |
63.48% |
| 2012-04-30 |
$1.38B |
$0.86B |
62.04% |
| 2012-01-31 |
$1.36B |
$0.84B |
61.56% |
| 2011-10-31 |
$1.33B |
$0.81B |
60.60% |
| 2011-07-31 |
$1.28B |
$0.77B |
59.98% |
| 2011-04-30 |
$1.23B |
$0.74B |
60.47% |
| 2011-01-31 |
$1.19B |
$0.70B |
59.03% |
| 2010-10-31 |
$1.16B |
$0.68B |
58.38% |
| 2010-07-31 |
$1.13B |
$0.65B |
57.45% |
| 2010-04-30 |
$1.12B |
$0.62B |
55.33% |
| 2010-01-31 |
$1.09B |
$0.60B |
55.46% |
| 2009-10-31 |
$1.08B |
$0.60B |
55.19% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.820B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
